Search Results - "Kramer, Mark S."

Refine Results
  1. 1

    Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK 1) antagonists by Rupniak, Nadia M.J, Kramer, Mark S

    Published in Trends in Pharmacological Sciences (01-12-1999)
    “…The development of small-molecule antagonists of the substance P (SP)-preferring tachykinin NK 1 receptor during the past decade represents an important…”
    Get full text
    Book Review Journal Article
  2. 2
  3. 3

    NK1 receptor antagonists for depression: Why a validated concept was abandoned by Rupniak, Nadia M.J., Kramer, Mark S.

    Published in Journal of affective disorders (01-12-2017)
    “…NK1 receptor antagonists were abandoned despite antidepressant efficacy in five randomized clinical trials. The loss of confidence may be attributed to the…”
    Get full text
    Journal Article
  4. 4

    Novel strategies for pharmacotherapy of depression by Maubach, Karen A, Rupniak, Nadia MJ, Kramer, Mark S, Hill, Raymond G

    Published in Current opinion in chemical biology (01-08-1999)
    “…Modulating monoamine activity as a therapeutic strategy continues to dominate antidepressant research, with a recent emphasis on agents with multiple targets,…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of Rizatriptan Tablets During and Between Migraine Attacks by Cutler, Neal R., Jhee, Stanford S., Majumdar, Anup K., McLaughlin, Debra, Brucker, Mary Jo, Carides, Alexandra D., Kramer, Mark S., Matzura-Wolfe, Deborah, Reines, Scott A., Goldberg, Michael R.

    Published in Headache (01-04-1999)
    “…Gastric stasis during migraine attacks results in delayed absorption of several orally administered antimigraine agents. This study, as part of a larger trial,…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist by Bristow, Linda J., Kramer, Mark S., Kulagowski, Jan, Patel, Smita, Ragan, C.Ian, Seabrook, Guy R.

    “…The discovery of a novel high-affinity and selective dopamine D4 receptor antagonist, L-745, 870, and the results of clinical trials with this compound are…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mucormycosis in a Renal Transplant Recipient With Successful Outcome by Henriquez, Mario, Levy, Richard, Raja, Rasib M, Kramer, Mark S, Rosenbaum, Jerry L

    “…MUCORMYCOSIS is usually a fatal disease that occurs in patients with uncontrolled diabetes mellitus, in patients with an abnormal immunologic system such as…”
    Get full text
    Journal Article
  11. 11

    Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial by Kramer, M S, Vogel, W H, DiJohnson, C, Dewey, D A, Sheves, P, Cavicchia, S, Little, P, Schmidt, R, Kimes, I

    Published in Archives of general psychiatry (01-10-1989)
    “…Fifty-eight actively psychotic inpatients who initially met criteria for long-standing schizophrenia and subsequently met Research Diagnostic Criteria for a…”
    Get more information
    Journal Article
  12. 12

    A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder by KRAMER, M. S, CUTLER, N. R, BALLENGER, J. C, PATTERSON, W. M, MENDELS, J, CHENAULT, A, RAM SHRIVASTAVA, MATZURA-WOLFE, D, LINES, C, REINES, S

    Published in Biological psychiatry (1969) (01-04-1995)
    “…The functional role of cholecystokinin in the central nervous system is unknown. The tetra peptide CCK-4 was previously observed to induce panic attacks in a…”
    Get full text
    Journal Article
  13. 13

    Resin hemoperfusion for acute drug intoxication by Rosenbaum, J L, Kramer, M S, Raja, R

    Published in Archives of internal medicine (1960) (01-03-1976)
    “…Eight patients with drug intoxication were hemoperfused on ten occasions at a blood-flow rate of 300 ml/min with a 650gm column of Amberlite XAD-4 resin, which…”
    Get more information
    Journal Article
  14. 14

    Repeated Peritoneal Dialysis in Treatment of Heart Failure by Raja, Rasib M, Krasnoff, Sidney O, Moros, Julio G, Kramer, Mark S, Rosenbaum, Jerry L

    “…A patient with refractory heart failure and anasarca underwent eight peritoneal dialyses during a 21-month period. Clinical response to the dialyses was…”
    Get full text
    Journal Article
  15. 15

    Neutralization of sensory-input modification of seizure thresholds in rats by Kramer, Mark S, Adler, Martin W

    “…Five experiments with a total of 162 male albino Sprague-Dawley rats demonstrated that exposing Ss to either intermittent sound or light stimulation…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    A placebo-controlled trial of L-365,260, a CCK B antagonist, in panic disorder by Kramer, Mark S., Cutler, Neal R., Ballenger, James C., Patterson, William M., Mendels, Joseph, Chenault, Alice, Shrivastava, Ram, Matzura-Wolfe, Deborah, Lines, Chris, Reines, Scott

    Published in Biological psychiatry (1969) (1995)
    “…The functional role of cholecystokinin in the central nervous system is unknown. The tetra peptide CCK-4 was previously observed to induce panic attacks in a…”
    Get full text
    Journal Article
  19. 19

    Heparin free dialysis: Comparative data and results in high risk patients by Caruana, Ralph J., Raja, Rasib M., Bush, Jasmine V., Kramer, Mark S., Goldstein, Stephen J.

    Published in Kidney international (01-06-1987)
    “…Heparin free dialysis: comparative data and results in high risk patients. Heparin free hemodialysis was compared to systemic heparinization, intermittent…”
    Get full text
    Journal Article
  20. 20